评论"使用多重免疫组织化学在头部和部状细胞癌中接受新辅助免疫疗法后瘤免疫微环境的表征"

Kohei Okuyama1, Souichi Yanamoto2

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.

Oral oncology
|February 12, 2025
PubMed
概括

新辅助免疫疗法通过增强抗癌CD8+T细胞来增强头支状细胞癌 (HNSCC) 的瘤免疫微环境 (TIME). 这种方法为开发新的生物标志物和个性化治疗提供了洞察力.